Hakutulokset - Liffick, Emily

O12.3. EFFECTS OF FINGOLIMOD, A POTENT ANTI-INFLAMMATORY AGENT, ON BRAIN STRUCTURE, FUNCTION, AND SYMPTOMS IN SCHIZOPHRENIA Tekijä Breier, Alan, Hummer, Tom, Vohs, Jennifer, Mehdyoun, Nicole, Liffick, Emily, Francis, Michael

Hae kokoteksti Hae kokoteksti

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study Tekijä Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN Tekijä Krege, John H, Rizzoli, Paul B, Liffick, Emily, Doty, Erin G, Dowsett, Sherie A, Wang, Jianing, Buchanan, Andrew S

Hae kokoteksti Hae kokoteksti Hae kokoteksti

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA? Tekijä Breier, Alan, Liffick, Emily, Hummer, Tom, Vohs, Jennifer, Mehdiyoun, Nicole, Yang, Ziyi, Saykin, Andrew J, McDonald, Brenna, Francis, Michael

Hae kokoteksti Hae kokoteksti

Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis Tekijä Francis, Michael Matthew, Hummer, Tom A., Vohs, Jenifer L., Yung, Matthew G., Liffick, Emily, Mehdiyoun, Nicole F., Radnovich, Alexander J., McDonald, Brenna C., Saykin, Andrew J., Breier, Alan

Hae kokoteksti Hae kokoteksti Hae kokoteksti